As required by CVS/caremark, for drug products that potentially qualify under

Part B or Part D, a pharmacy provider must promptly obtain any necessary

information from the enrollee or prescriber to properly submit the drug for

processing (e.g., to the Part B plan or the Part D plan). Pursuant to your

Medicare Part D contract, it is the responsibility of the pharmacy provider to

determine whether the drug is a Part B or Part D covered drug. Only a drug that

is determined to be a Part D claim should be submitted under the Medicare Part

D program.

CVS/caremark administers the prescription benefits for Tyson Foods.

Tyson Foods’ formulary will change effective January 1, 2016. This will result

in changes including, but not limited to, drug copays, tier changes, drug

exclusions, changes in allowed quantities, step therapy changes or additions,

and/or prior authorization additions.

• This recall has been initiated due to the products being found to potentially have inaccurate dosage delivery.

Immediately examine your inventory and quarantine any product subject to recall. In addition, if you may have further distributed this product past the recall date, please identify your affected customers and notify them at once of this product recall. We look forward to working together to provide quality pharmacy services to our members.